Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study - Wikidata - awgldk - TriplyDB

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

http://www.wikidata.org/entity/Q33978090

about

cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia New concepts of resistance in the treatment of Helicobacter pylori infections H pylori antibiotic resistance: prevalence, importance, and advances in testing Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment.Relationship between the severity of hepatitis C virus-related liver disease and the presence of Helicobacter species in the liver: a prospective study.Evaluation of clarithromycin resistance and cagA and vacA genotyping of Helicobacter pylori strains from the west of Ireland using line probe assays.Mechanism of metronidazole resistance in Helicobacter pylori: comparison of the rdxA gene sequences in 30 strains.Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan Sequential inactivation of rdxA (HP0954) and frxA (HP0642) nitroreductase genes causes moderate and high-level metronidazole resistance in Helicobacter pylori Roles of FrxA and RdxA nitroreductases of Helicobacter pylori in susceptibility and resistance to metronidazole.Clinical relevance and diversity of two homologous genes encoding glycosyltransferases in Helicobacter pylori.Green Synthesis of Silver Nanoparticles: Structural Features and In Vivo and In Vitro Therapeutic Effects against Helicobacter pylori Induced Gastritis Antimicrobial susceptibility of Helicobacter pylori strains isolated from patients in Shiraz, Southern Iran.Trends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Multicenter survey of routine determinations of resistance of Helicobacter pylori to antimicrobials over the last 20 years (1990 to 2009) in Belgium.Antibiotic susceptibility profile of Helicobacter pylori isolated from the dyspepsia patients in Tehran, Iran Risk factors for atrophic chronic gastritis in a European population: results of the Eurohepygast study.Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.Helicobacter pylori detection and antimicrobial susceptibility testing.Efficacy of a "Rescue" Ciprofloxacin-Based Regimen for Eradication of Helicobacter pylori Infection after Treatment Failures Variability in Prevalence of Helicobacter pylori Strains Resistant to Clarithromycin and Levofloxacin in Southern Poland Multilaboratory comparison of proficiencies in susceptibility testing of Helicobacter pylori and correlation between agar dilution and E test methods.Clinical evaluation of four one-week triple therapy regimens in eradicating Helicobacter pylori infection.Validation of a fluorescence in situ hybridization method using peptide nucleic acid probes for detection of Helicobacter pylori clarithromycin resistance in gastric biopsy specimens.Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population Intrafamilial spread of the same clarithromycin-resistant Helicobacter pylori infection confirmed by molecular analysis.Pepsinogen A, pepsinogen C, and gastrin as markers of atrophic chronic gastritis in European dyspeptics.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North Distribution of antibiotic MICs for Helicobacter pylori strains over a 16-year period in patients from Seoul, South Korea.Detection of genotypic clarithromycin-resistant Helicobacter pylori by string tests.In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori.Alterations in penicillin-binding protein 1A confer resistance to beta-lactam antibiotics in Helicobacter pylori Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori Green synthesis of silver nanoparticles through reduction with Solanum xanthocarpum L. berry extract: characterization, antimicrobial and urease inhibitory activities against Helicobacter pylori.Helicobacter pylori and antibiotic resistance.

P2860

Q24550819-25E9C8DD-4F65-4E80-A9B2-65103D0789C8 Q24622513-56E2B542-7DC2-48CB-AFDF-406C129BB97C Q24685864-8251DE16-C054-439D-B638-C1977370F288 Q24798214-D7A3E8E7-BDD4-42DB-860B-C701CF4AEE7F Q24802227-96819338-136B-4B66-BC2B-F723533A82F1 Q30453034-B64590A8-4FA5-4A35-A214-13085F0D3DB0 Q33866459-BD6D5EE7-9AA5-4E6D-A137-93762DAE9630 Q33972380-C9651262-3C90-4FCB-AD98-C533A05A41AC Q33980330-3BFF492D-2A1E-434C-B1C3-BB2A5D1A8B00 Q33980346-6CEE7BB7-DE92-4ECB-BEEC-AB3E69A5499E Q33994585-ED328972-ED7D-4D8C-90D6-5375E48847FC Q33996752-14B3931A-C342-4DEB-92C4-14E6D2687AF8 Q34046265-CD9B7919-A842-4A21-AADB-6AF7D2949A27 Q34151373-05910831-BDEC-4199-9CC2-119BACDA5D3C Q34385180-A6E31843-F72E-4A80-B15A-3267B36A1BEB Q34983201-ED49ABC9-A7F8-426B-96E8-A0B9D53C6A6B Q35066862-2F0E739C-C06F-418D-9B49-80AE78C1F704 Q35098365-4BB31281-CAA8-4828-BAA9-F737112BAA12 Q35594635-F7AE9DA3-0C3E-4959-9347-FF0DC51647C2 Q35760968-BA5A72FA-2CC6-4BE4-A8CE-2F5304EEF226 Q35783436-B094128B-8584-4D02-BBE1-5A91416EB681 Q35986780-58CCE0EA-167F-416C-9B88-DB5A8AEEEB9B Q36010979-36220C4E-EB1E-4754-81AB-0332A27DAFF9 Q36047451-B2CB55DB-3E49-40C0-823E-6C0747AABDEF Q36474195-F55E5981-E2C1-4118-BE7B-ED7306E4AAC5 Q37026545-E17F943F-8BA9-430D-989B-6F1D5E834A3D Q37059284-31FA8CB4-8296-42C5-BF18-3D58FCE02079 Q37155972-E3231390-C308-4BBE-A7BF-9CEB8BFBE769 Q37355104-98CF0E6E-4EA3-4E17-9E64-76D3B8660F30 Q37378899-71437535-CC55-4202-9E19-05469875100A Q37558559-85947E44-A8F9-4240-BC44-82BCC1CC8DB4 Q37624449-7FB89286-4448-4C16-A44C-D73D304D05CE Q37660716-B2F5FB50-3721-4598-BA32-10A0A78F01F0 Q39474501-CEEBAC8E-6AF6-4A8A-BF9B-3C0FB817AD7F Q39477186-E400B57D-0167-42BC-B617-00C80AFA3F1C Q39537361-BDE764C3-6BB8-47C7-98DD-E52BD7098CA2 Q39652220-F9F3B345-9536-4240-8B1C-D3733D8C48C4 Q39733016-0DBC662C-461B-4916-871E-5AF233B9CB1A Q42140862-BBA42EA8-E139-4CB5-9D9C-AE159BDB9C9F Q42735860-11BAE036-13B4-49FF-8CDE-500B4134A9C8

P2860

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

http://www.wikidata.org/entity/Q33978090

description

1999 nî lūn-bûn

@nan

1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@ast

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@en

type

label

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@ast

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@en

prefLabel

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@ast

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@en

P1433

Q33978090-94B8CCC2-A156-4549-972C-1C7121F0E7D6

P1476

Q33978090-30CADA57-8100-4031-B375-A7BAA3F86453

P2093

Q33978090-23B9C5FF-7F05-4873-BA72-A1448FEA2FD1

Q33978090-276026BA-7ED7-4E69-B199-0897FA3D44DA

Q33978090-5DA08026-FA39-4313-933C-7AB6540A7C42

Q33978090-688CCDA0-1D29-41D7-BDF4-FE93D983028D

Q33978090-70B284E5-1B15-4B1D-B3BF-5110F45C6DBF

Q33978090-72C76141-A04D-4842-B7AB-A7B648891CBB

Q33978090-8BED515B-765B-48AE-93D9-4363F94F8105

Q33978090-E3A181E2-CB38-4F30-86DD-7B9CE7748C38

Q33978090-EC9C3DB8-9608-422F-A79F-1D19F6E5B6F9

P2860

Q33978090-04E44527-6F4F-4526-B070-6F06F4C09E61

Q33978090-1E86628E-D5AF-4EC1-85FC-809C03B6AFE4

Q33978090-2DC88987-3E76-497F-BE90-04A51A53703F

Q33978090-482402AB-9D3F-4329-BC86-B128D11351AA

Q33978090-4D249F7B-2D58-4A42-961E-CF757AAB4304

Q33978090-5708B71D-5BF0-4F3E-B2D6-C534259A33CF

Q33978090-5B19AA61-A0B4-4AA6-83CE-DA3D583F79B1

Q33978090-624DF659-F317-4850-9176-5C055E0DFB15

Q33978090-649400DC-87AA-4D8B-8019-381B58472801

Q33978090-68E3D326-88FC-4DCF-B64B-7BEFF878E5C4

P304

Q33978090-5B02A444-B75D-419B-A583-14A4A8C3FB76

P31

Q33978090-5E79341B-6476-4050-9010-520604292D63

P356

Q33978090-E7C1506B-E095-4E39-8D3B-212602BF99C8

P407

Q33978090-CA8663DF-EDCA-427C-A59F-832E3A6745F3

P433

Q33978090-DEA1823A-4A40-4E33-B3AB-9F4592C44B6D

P478

Q33978090-FEADE7ED-A304-4601-860E-BB4E240986D3

P50

Q33978090-FDEDDC92-A2B4-422F-9BBE-6A59E5F8DEEF

P577

Q33978090-69B540C7-364A-4BC5-99AB-7CB7E2E5F430

P698

Q33978090-913AA59C-248E-476C-A91D-3254C7D2C372

P921

Q33978090-727F824B-A0B8-4D32-86C0-2ED2D329237F

Q33978090-9843ABC1-EFE8-418D-A21F-5345F5970453

P932

Q33978090-B2F4ECA9-33E4-4B0C-9C75-FC04220CD7C9

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Antimicrobial susceptibility t ...... center trial: the MACH 2 study

@en

P2093

C F Burman

http://www.w3.org/2001/XMLSchema#string

C O'Morain

http://www.w3.org/2001/XMLSchema#string

E Bayerdörffer

http://www.w3.org/2001/XMLSchema#string

F Mégraud

http://www.w3.org/2001/XMLSchema#string

M Wrangstadh

http://www.w3.org/2001/XMLSchema#string

N Lehn

http://www.w3.org/2001/XMLSchema#string

P Unge

http://www.w3.org/2001/XMLSchema#string

S V van Zanten

http://www.w3.org/2001/XMLSchema#string

T Lind

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical relevance of resistant strains of Helicobacter pylori: a review of current data

Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Comparative evaluation of three selective media and a nonselective medium for the culture of Helicobacter pylori from gastric biopsies

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Antimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.

Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes.

Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents

One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group

Comparative evaluation of the E test, agar dilution, and broth microdilution for testing susceptibilities of Helicobacter pylori strains to 20 antimicrobial agents.

Evaluation of the E test for quantitative antimicrobial susceptibility testing of Helicobacter pylori.

P304

2747-2752

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.43.11.2747

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10543758

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori

multicenter trial

P932

89554

http://www.w3.org/2001/XMLSchema#string